Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.150
+0.175 (5.88%)
At close: Apr 16, 2026

Jerusalem Pharmaceuticals Ratios and Metrics

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
805949494236
Market Cap Growth
91.80%20.04%0.69%15.82%16.13%2.15%
Enterprise Value
675343413937
Last Close Price
2.231.591.301.251.040.86
PE Ratio
11.098.0913.689.838.237.72
PS Ratio
2.271.661.731.731.281.10
PB Ratio
1.290.940.960.990.910.74
P/TBV Ratio
1.340.981.001.030.940.80
P/FCF Ratio
76.4055.796.948.723.6213.20
P/OCF Ratio
32.0323.395.877.443.478.42
EV/Sales Ratio
1.881.501.521.471.181.12
EV/EBITDA Ratio
6.265.067.645.735.195.20
EV/EBIT Ratio
7.295.799.056.496.206.48
EV/FCF Ratio
63.3050.296.107.443.3513.40
Debt / Equity Ratio
0.020.020.020.040.030.04
Debt / EBITDA Ratio
0.090.090.180.230.200.25
Debt / FCF Ratio
0.890.890.150.320.130.68
Net Debt / Equity Ratio
-0.23-0.23-0.14-0.06-0.09-0.04
Net Debt / EBITDA Ratio
-1.39-1.39-1.30-0.41-0.53-0.29
Net Debt / FCF Ratio
-13.83-13.83-1.04-0.53-0.34-0.74
Asset Turnover
0.500.500.450.470.540.56
Inventory Turnover
2.112.112.101.721.791.61
Quick Ratio
3.363.363.342.972.882.80
Current Ratio
4.274.274.294.113.864.25
Return on Equity (ROE)
12.90%12.90%7.21%10.45%10.77%9.55%
Return on Assets (ROA)
7.99%7.99%4.77%6.60%6.45%6.06%
Return on Invested Capital (ROIC)
14.42%15.82%8.14%11.48%11.22%10.07%
Return on Capital Employed (ROCE)
13.50%13.50%8.70%12.10%12.60%10.80%
Earnings Yield
9.02%12.36%7.31%10.17%12.15%12.95%
FCF Yield
1.31%1.79%14.42%11.46%27.64%7.58%
Dividend Yield
1.27%-2.19%2.83%5.10%4.92%
Payout Ratio
8.01%8.01%33.52%36.63%29.90%20.25%
Buyback Yield / Dilution
-0.08%-0.08%----
Total Shareholder Return
1.19%-0.08%2.19%2.83%5.10%4.92%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.